

Cover Story
COVID-19 & CancerFreeGuest Editorial
The past two decades have brought hope to myeloma patients, as the majority benefit from the significant advances in chemotherapy.
Free
By Matthew Bin Han Ong
In Brief
Clinical Roundup


Drugs & Targets


Trending Stories
- A farewell post by an unidentified NCI employee triggers an accusation of “undermining the Trump administration”
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- The other side of the patient portal: Reflections from a cancer center leader
- RFK Jr. floats the idea of barring government scientists from publishing in leading medical journals due to “corruption”
- Surviving cancer is often not a patient’s most challenging battle
- We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James